Insight journal, Insight journal - Company

SciClone Pharmaceuticals: Your marketing partner for China

Posted on 18 August 2014

Tags: , ,

Sciclone Pharmaceuticals is a specialty pharmaceutical company focused on developing and marketing products to treat oncology, infectious diseases and urology.

The company’s strategy is to in-license new or differentiated products then market them to the patients of China. Over the years and with a decade of commercial experience the company has brought in some big products from the top 50 pharmaceutical companies.

In 2012 SciClone Pharmaceuticals had pain treatment Tramadol approved for marketing in China and now the company is working with BTG/Biocompatibles to potentially market the product DC Bead which delivers chemotherapy drugs to liver cancer tumours. Other products on the development table are Zensin’s Neucardin for chronic heart failure and Bioalliance’s Loramyc which is indicated for oropharyngeal candidiasis. With all these arrangements SciClone gain exclusive sales rights for China.

Although the company is focused in China, it actually based in the US this gives it a wide global reach and makes it easier to negotiate deals for US manufactured products.

SciClone also has its own flagship product ZADAXIN which is indicated for Hepatitis B, Hepatitis C and certain cancers. The product has been on the market some time having been approved back in the 1990’s.

Partnering to in-license

In order to build up its marketed portfolio in China, SciClone wishes to in-license further late stage clinical development products. The company is also interested in products that are approved in at least one of the big pharmaceutical markets or any differentiated products that are already marketed in China used in hospitals.

Andrew Wong, Vice President of Business development is the gentleman to contact for any potential deal discussions.

Since 2009 SciClone Pharmaceuticals announced 8 partnering / licensing deals, which is quite a lot more than many of the biotech companies currently at work out there.

Partnering Outreach

SciClone Pharmaceuticals is routinely present at a large number of partnering events throughout the year.

Partnering events are a great place to meet lots of potential partners face to face in a small amount of time.

Events with SciClone Pharmaceuticals presence include but are not limited to:

  • BIO International Convention and Business Forum
  • BioEurope / BioEurope Spring

For a full list of forthcoming partnering events where you could meet with SciClone Pharmaceuticals in person visit Current Partnering’s Event calendar.

Contacting SciClone Pharmaceuticals for partnering

SciClone Pharmaceuticals can be contacted in relation to partnering through a number of channels.

Here is a list of the most common channels: 

Partnering events: face to face contact is generally considered the most effective form of contact. Partnering events not only allow face to face discussions but also contact with multiple companies for the price of one flight and hotel reservation. This benefit makes partnering events the most cost effective method of making personal introductions as a start point for partnering discussions.

See Current Partnering’s event calendar for details of forthcoming events. 

Direct contact: there are several sources of direct contact with Sciclone’s business development team

  • Phone: Picking up the phone and speaking with an individual is the best form of non-face to face contact as it allows your name and voice to be remembered and associated with an opportunity.
  • Email: Sending an email is another good way of making contact. Ideally, research the individual responsible for the therapy/technology area being targeted and get in touch. Email contact to a named individual view the list of contacts at SciClone’s website for details.
  • LinkedIn: Business to business contact is increasingly taking place via LinkedIn, the global online networking channel. Many of SciClone’s business development executives have LinkedIn profiles and can be found by viewing the company’s profile. Visit SciClone’s LinkedIn page here.

Opportunity submission form: the least favourable channel but worth using if you do not have access to the other channels mentioned above. SciClone Pharmaceuticals does not provide an online opportunity submission form.

SciClone Pharmaceuticals partnering at Current Agreements

View all partnering deals for SciClone Pharmaceuticals:  2014 | 2013 | 2012 | 2011 | 2010 | 2009

Full details on each deal can be found at Current Agreements (subscription required)

Or purchase report: Partnering Agreements with SciClone Pharmaceuticals 2009-2014 

 

More   

Summary profile data for SciClone Pharmaceuticals

Partnering activity for SciClone Pharmaceuticals

M&A activity for SciClone Pharmaceuticals 

 

Available reports from Current Partnering

Report: Partnering Agreements with SciClone Pharmaceuticals 2009-2014 

Report: Partnering Deals and Alliances with Big Biotech

Available resources for deal coverage for SciClone Pharmaceuticals

Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more

Read: more on SciClone Pharmaceuticals company profile, recent partnering, M&A and financing news and articles

 

Related

Report: Finding Biopharma Licensing and Collaboration Partners

View: Current Partnering Insight Partnering Scorecard – view top life science partnering deals by value

View: Current Partnering Insight M&A Scorecard – view top life science M&A deals by value

View: Current Partnering Insight Deal Metrics – the latest deal trend infographics for life science deal making

View: Current Partnering Insight Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity

Signup: Current Partnering Insight Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now

Signup: Current Agreements Insight Deals Review – monthly newsletter - reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now

View: Top 50 pharma – overview of top 50 pharmaceutical companies by revenue – partnering activity, deal news, partnering dealtalk

View: Top 50 biotech – overview of top 50 biotechnology companies by revenue – partnering activity, deal news, partnering dealtalk

Follow us on: LinkedIn Current Partnering | LinkedIn Business Development Network | @Currentpartner on Twitter

Print Friendly, PDF & Email

Leave a Reply

 

cpbannerad300x150new1gif
rauconbadgejpg
e80banner300x150animgif
cpbannerad300x150new2gif
e80banner300x150animgif
a1banner300x150animgif